On the other hand, several publications suggest that DDR1 overexpression at protein levels has shown to be associated with cancer progression (176–179) and metastases (180), and the increase of DDR1 mRNA levels was proved to be associated with worse overall survival in all subtypes of breast cancer patients, and particularly in TNBC (152). This evidence concerns the gene DDR1 and breast carcinoma.